PACE4 is an important driver of ZR-75-1 estrogen receptor-positive breast cancer proliferation and tumor progression-Reference-Cited by-同舟云学术

PACE4 is an important driver of ZR-75-1 estrogen receptor-positive breast cancer proliferation and tumor progression

Published:2017-08 Issue:5 Volume:96 Page:469-475
ISSN:0171-9335
Container-title:European Journal of Cell Biology
language:en
Short-container-title:European Journal of Cell Biology

Author:

Panet François,Couture Frédéric,Kwiatkowska Anna,Desjardins Roxane,Guérin Brigitte,Day Robert

Funder

Canadian Cancer Society

Publisher

Elsevier BV

Subject

Cell Biology,General Medicine,Histology,Pathology and Forensic Medicine

Reference41 articles.

1. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists;Badve;Mod. Pathol.,2011

2. Recombinant humanized anti-HER2 antibody (Herceptin™) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts;Baselga;Cancer Res.,1998

3. Clinical trials of Herceptin®(trastuzumab);Baselga;Eur. J. Cancer,2001

4. The proprotein convertases furin and PACE4 play a significant role in tumor progression;Bassi;Mol. Carcinog.,2000

5. Proprotein convertases:master switches in the regulation of tumor growth and progression;Bassi;Mol. Carcinog.,2005

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of PCSK6 polymorphisms with susceptibility risk of large artery atherosclerotic stroke;2024-01-30

2. Proprotein Convertase Subtilisin/Kexin 6 in Cardiovascular Biology and Disease;International Journal of Molecular Sciences;2022-11-03

3. Testicular Germ Cell Tumours and Proprotein Convertases;Cancers;2022-03-23

4. The effects and possible mechanism of action of apolipoprotein M on the growth of breast cancer cells;Molecular Biology Reports;2021-11-13

5. Up-regulation of microRNA-135 or silencing of PCSK6 attenuates inflammatory response in preeclampsia by restricting NLRP3 inflammasome;Molecular Medicine;2021-07-23